Showing results (591-600 of 1,995) with videos related to
Sort By:
Pageof 200
The Lancet. Neurology|February 20, 2021
Risk of stroke in relation to degree of asymptomatic carotid stenosis: a population-based cohort study, systematic review, and meta-analysisDominic P J Howard, Liam Gaziano, Peter M Rothwell, et al.The Lancet. Neurology|September 26, 2022
Optic neuritis and autoimmune optic neuropathies: advances in diagnosis and treatmentJeffrey L Bennett, Fiona Costello, John J Chen, et al.The Lancet. Neurology|May 24, 2011
Development of biomarkers for Huntington's diseaseDavid W Weir, Aaron Sturrock, Blair R LeavittThe Lancet. Neurology|July 22, 2011
The projected effect of risk factor reduction on Alzheimer's disease prevalenceDeborah E Barnes, Kristine YaffeThe Lancet. Neurology|July 23, 2011
Natalizumab treatment for multiple sclerosis: updated recommendations for patient selection and monitoringLudwig Kappos, David Bates, Gilles Edan, et al.The Lancet. Neurology|June 21, 2011
Mesenchymal stem cells for the treatment of multiple sclerosis and other neurological diseasesAntonio Uccelli, Alice Laroni, Mark S FreedmanThe Lancet. Neurology|June 21, 2011
Clinical amyloid imaging in Alzheimer's diseaseKarl Herholz, Klaus EbmeierThe Lancet. Neurology|June 28, 2011
Long-term safety and efficacy of rotigotine transdermal patch for moderate-to-severe idiopathic restless legs syndrome: a 5-year open-label extension studyWolfgang Oertel, Claudia Trenkwalder, Heike Beneš, et al.The Lancet. Neurology|July 12, 2011
Simvastatin as add-on therapy to interferon β-1a for relapsing-remitting multiple sclerosis (SIMCOMBIN study): a placebo-controlled randomised phase 4 trialPer Soelberg Sorensen, Jan Lycke, Juha-Pekka Erälinna, et al.The Lancet. Neurology|April 13, 2011
A double-blind, delayed-start trial of rasagiline in Parkinson's disease (the ADAGIO study): prespecified and post-hoc analyses of the need for additional therapies, changes in UPDRS scores, and non-motor outcomesOlivier Rascol, Cheryl J Fitzer-Attas, Robert Hauser, et al.Pageof 200